Eight new FK228 analogues were synthesized.
These analogues were evaluated against HDACs and 39 human cancer cell lines.
Some of these analogues exhibited very high HDAC1 (class I) isoform selectivity.
Potent and highly isoform-selective HDAC1 inhibitors were identified.
Novel aspects of SAR were revealed.